Chief Executive Officer | Prime Healthcare Region I Corporate Chief Medical Officer | Prime Healthcare

Prime Healthcare

Sunny Bhatia, MD is the chief executive officer and chief medical officer for Prime Healthcare’s Region I which includes Prime Healthcare’s 17 hospitals located in California and Nevada. Dr. Bhatia also serves as the chief medical officer at Sherman Oaks Hospital and Encino Hospital Medical Center, two of Prime Healthcare’s acute care, community hospitals located in LA County. Under Dr. Bhatia’s leadership, Prime Healthcare’s hospitals have earned accolades for quality, patient safety and performance over the past year from nationally recognized healthcare rating agencies. As CMO, Dr. Bhatia ensures that Prime’s hospitals and physicians in California and Nevada are aligned in their goals of providing safe and high-quality care. Through Dr. Bhatia’s leadership, physician-led teams at the hospital and corporate levels have designed and implemented groundbreaking clinical programs.


President & Co-Founder

24 Hour Home Care

Ryan Iwamoto is president and co-founder of 24 Hour Home Care, one of Los Angeles’ largest homecare companies. A LA native, Iwamoto co-founded 24 Hour in 2008 at age 26. Over the last five years, 24 Hour has grown from $48 million to $110 million projected revenue in 2020. It started as a $160,000 self- and family-funded venture. Now it is an enterprise with 20 locations and 10,000 caregivers serving 10,000 seniors and individuals with developmental disabilities each year. Iwamoto’s leadership during COVID-19 is an example of his leadership skills. Right away he prioritized safety above all else. He spearheaded the organization’s industry-leading S.A.F.E.R. at home program to safely care for vulnerable populations through investing in training, PPE, and safety procedures. This enabled 24 Hour Home Care to become one of few home care companies to alleviate hospitals in LA by caring for recovering COVID+ seniors in their homes.


Medical Director of Infection Prevention and Antimicrobial Stewardship

Keck Medicine of USC

In years without an international pandemic, the role of an infection preventionist at a hospital might fly under the radar. However, with COVID-19 dominating health care for the past six months, Neha Nanda, MD, medical director of infection prevention and antimicrobial stewardship with Keck Medicine of USC, has risen to well-deserved prominence. Under her steady, expert hand, Dr. Nanda has taken the lead in infection prevention and policy at Keck Medicine’s three hospitals and some 80 ambulatory locations during the outbreak. She coordinated hospital restructuring to allow for isolation and quarantine of COVID-19 patients, oversaw a necessary cessation of services in anticipation of a surge, and developed a plan for the strategic resumption of elective procedures and surgeries. Through her working relationship with national and local health officials to create best practices throughout the health system of 2,000 doctors and over one million patients.



MiraKind, MiraDx

Dr. Joanne Weidhaas, MD, PhD, MSM is the co-founder of MiraDx and a professor and vice-chair in the department of radiation oncology at UCLA. MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer treatment. When the pandemic hit, Dr. Weidhaas decided to take action and use MiraDx’s existing technology to develop a COVID-19 test. Because MiraDX’s cancer research has been focused on molecular studies of DNA and RNA, Dr. Weidhaas was able to use her expertise to quickly repurpose most of their equipment and protocols to test for COVID-19. The test she and her team designed uses highly-sensitive tests which can detect if someone is contagious at the early stage of infection. MiraDx was able to mobilize to provide immediate COVID-19 tests for essential workers, reaching the capacity for 10,000 tests per day, with an Accuracy Rate of 95+%.



President & CEO

Emanate Health

Rob Curry, the president and chief executive officer of Emanate Health, oversees the largest health care system in the San Gabriel Valley. Curry’s leadership has been invaluable in guiding Emanate Health during the pandemic to ensure financial sustainability, preserve staff positions, treat those with and without COVID-19, and inspire confidence that everything that could be done is being done to bring the surrounding communities back to good health. He serves as the board chair for Private Essential Access Community Hospitals (PEACH) - a network of private, core safety net hospitals in California that care for a disproportionate share of low-income, medically vulnerable patients. Curry is currently a fellow in the American College of Healthcare Executives. He serves on the board of directors for the California Hospital Association and also serves as a member of its executive committee. He previously served as a member on the board of the American Hospital Association, Region 9.



Adventist Health Glendale

Alice Issai joined Adventist Health Glendale as the new president in July 2018. She previously was with Keck Medicine of USC where she served as chief operating officer for Keck Hospital of USC and USC Norris Cancer Hospital. Under Issai’s leadership, Adventist Health Glendale began the year with the Centers for Medicare & Medicaid Services (CMS) awarding it five stars - the highest-possible - for quality. Fewer than 300 hospitals nationwide, and only five in the Los Angeles area, earned five stars. Adventist Health Glendale was recognized by U.S. News & World Report as the 10th Best Hospital among the 130+ area hospitals and received The Leapfrog Group’s A grade for the 10th consecutive time, an achievement fewer than 3.5% of hospitals nationwide can boast. Additionally, the hospital earned top recognition for its comprehensive stroke care from the American Heart Association/American Stroke Association.


President, UCLA Health, CEO, UCLA Hospital System, Associate Vice Chancellor, UCLA Health Sciences

UCLA Health

Johnese Spisso has been president of UCLA Health, CEO of UCLA Hospital System and associate vice chancellor of UCLA Health Sciences since 2016. With 30 years of experience, she is a nationally recognized academic health care leader, overseeing operations of UCLA’s hospitals, clinics and the health system’s regional outreach strategy. Spisso led UCLA’s expansion to provide convenient access to care throughout Southern California, with more than 200 clinics recording more than 2.8 million outpatient visits in 2019. She also has led the effort to accomplish essential clinical goals at UCLA Health. During the COVID-19 pandemic, Spisso rallied UCLA Health’s team to an early response and encouraged the public to adopt life-saving practices. From the launch of the COVID-19 Command Center in early March, Spisso oversaw procurement of PPE, surge planning, operations, logistics and all other critical aspects of the health system.


President and CEO

City of Hope

Robert W. Stone, City of Hope’s president and chief executive officer, leads a world-renowned independent biomedical research and treatment center for cancer and diabetes which is setting the standards for precision oncology care, delivering impactful research discoveries, collaborating with industry and philanthropic partners, and influencing healthcare policy to transform the future of health. Stone, a lawyer who moved up the ranks of the organization to assume the chief executive role in 2014, possesses a unique perspective and understanding of the dynamic healthcare environment and an ability to make big bets on priorities that matter most, inspiring the enterprise to make his vision a reality. He has driven City of Hope’s rapid evolution, including expanding access to its exceptional patient-centered care, as it has grown from a single site outside of Los Angeles to a clinical network spanning 30 locations throughout California.



Surgeon-in-Chief Vice Dean, Academic Affairs Vice President, Interventional Services


Bruce L. Gewertz, MD has been a leading medical expert in the Los Angeles area and nationally for more than 25 years. The research of Dr. Gewertz focuses on human factors in delivery of health care and the distribution of surgical services. His clinical interests include cerebrovascular disease, especially intraoperative neurophysiologic monitoring and outcome analysis, aortic aneurysmal disease, and mesenteric ischemic syndromes. Prior to joining Cedars-Sinai, Dr. Gewertz served on the faculty at the University of Chicago (1981-2006). There he enjoyed a regional and national referral practice in vascular surgery and established a fully funded laboratory focused on cellular mechanisms of ischemia-reperfusion injury. In his very substantial body of basic science work, Dr. Gewertz was consistently funded by the NIH and American Heart Association and published his work in the most highly refereed research journals. 


Director, Neuro-Oncology; Chair and Professor, Department of Translational Neurosciences and Neurotherapeutics

Pacific Neuroscience Institute

Dr. Santosh Kesari, M.D., Ph.D., is a board-certified neurologist and neuro-oncologist who leads the Pacific Neuroscience Research Center and Pacific Neuroscience Institute. He also serves as director of neuro-oncology at Providence Saint John’s Health Center and chair of the Department of Translational Neurosciences and Neurotherapeutics at John Wayne Cancer Institute. Dr. Kesari specializes in personalized medicine for patients with malignant brain tumors. His experience in precision therapeutic strategies targets brain tumors at the molecular level to eliminate the disease. Dr. Kesari’s research efforts have focused on cancer stem cells, their role in the formation of brain tumors, and their resistance to treatment. His goal is to advance neurological medicine by developing targeted drugs to eradicate brain tumors.


Chief Administrative Officer

CHA Hollywood Presbyterian Medical Center

An internationally renowned authority in the subspecialty of skull base surgery, Dr. Joung Lee, who currently serves as chief administrative officer at CHA Hollywood Presbyterian Medical Center, previously established one of the world’s largest skull base surgery programs at the Cleveland Clinic in Cleveland, Ohio where he served as Professor and the Founding Director of the clinic’s Skull Base Surgery Center from July 1993 to March 2014. During his vast experience spanning over 4000 complex cranial surgery cases, he has pioneered many innovative surgical techniques which are currently used by neurosurgeons throughout the world. Dr. Lee has been recognized since 2005 as one of the “Best Doctors in America,” and has been a recipient of the “Patient’s Choice Award” for over 10 years. He has also authored more than 100 publications and edited two books, including a comprehensive textbook on meningioma.


Senior Vice President and Chief Medical Officer

Children’s Hospital Los Angeles

James Stein, MD, is CHLA’s inaugural senior vice president and chief medical officer. Dr. Stein is responsible for developing care delivery systems that set the bar in all metrics. From cancer surgeries to separating conjoined twins, Stein is a renowned pediatric surgeon. As CMO, he is a physician leader overseeing CHLA’s COVID-19 crisis command team. He has exhibited grace under fire and led with calm reassurance. During the pandemic, CHLA developed its own robust viral testing system for patients, staff and community partners; maintained supplies of PPE and created a specialized unit for COVID-19 positive patients. More than 15,000 on-site viral tests were conducted with turn-around times of 24 hours. Universal masking and daily health screenings for staff and visitors ensured a safe environment for patients, families and workers – protocols that have now been shared nationally through his leadership on several committees, enabling CHLA to provide care for underserved populations.



System Vice President and Associate General Counsel - Legal Compliance and Regulatory Affairs

CommonSpirit Health / Dignity Health

Suzan Konell has provided guidance to the health system on a wide range of legal issues involving compliance and regulatory affairs. In addition to the extensive legal guidance she provides across the organization, Suzan has been heavily involved in philanthropic initiatives for Dignity Health in Los Angeles and the broader Southern California region, including Northridge Hospital Medical Center’s Center for Assault Treatment Services (CATS), California Hospital Medical Center and its Hope Street Community Benefit Programs, the Human Trafficking Response Program and more. The Hope Street Margolis Family Center became a nationally recognized Project Head Start Program and expanded to touch children and their families to include education, literacy training, and mental health services to assure that the children had the opportunity to have healthy productive lives. Konnell balances providing her legal expertise in a dynamic, fast-moving organization with these types of efforts to better the communities that Dignity Health serves.




Damaris Medina serves on Buchalter’s Board of Directors, is co-chair of Buchalter’s Life Sciences Industry group, chair of the Women of Buchalter Committee and a member of various other committees including the firm’s Partnership Evaluation committee. Medina successfully litigates numerous complex exposure cases against major health plans recovering millions of dollars on behalf of health care providers, and routinely advocates for health care providers by advancing and establishing new legal theories that are significant to the health care provider industry. Medina is a frequent speaker and author on healthcare industry topics and serves as the Director of the Board for the Urgent Care Association of America. Her standing as a top attorney in the healthcare field is routinely recognized by industry publications. This was recently reinforced by her selection as one, of only four, leading attorneys in the field to teach mediation and arbitration of healthcare matters to JAMS’ neutrals in California.




PCH Benefits

Tom Means is a 15-year veteran of the health and life insurance industries, spending his entire professional career focused on strategies and solutions for employee benefits and executive benefits. He is an expert on the Affordable Care Act (“ObamaCare”), and its potential impacts on individuals and businesses. As an agent/broker, Means’ role is to guide clients to the right strategies and plan designs for them and/or their businesses. Means is always searching for compliant health insurance solutions to best serve you, your employees, your business and your budget. While many agents/agencies are myopic, contending with conflicting ideologies of either planning for today versus planning for tomorrow, Means continues to display his ability to do both successfully. And, in the midst of a worldwide pandemic, he was one of the first to go virtually and did so seamlessly.



Paz Holding Inc. dba A+ Insurance Service

Naama O. Pozniak is a creative, globally-minded health insurance strategic advisor, meditation coach, and speaker. She has served the American insurance industry for 30+ years specializing in healthcare reform, employee benefits, international travel insurance, and Medicare. Pozniak marries her fields of expertise through presentations and speaking events spreading the message of reducing healthcare costs and stress reduction with meditation and yoga. Her mission is to empower other insurance professionals to start practicing and share these techniques with clients, employers, and/or peers. Her innovative ideas on healthcare have been published in American’s Benefit Specialist Magazine, Insurance News Net Magazine, Benefit News, Cal Broker Magazine and more. She has been recognized by a number of prestigious awards, including Employee Benefits Adviser’s 2019 “Wellness Adviser of the Year” and the San Fernando Valley Chamber of Commerce’s SIBBIE Award for 2019.




Since its founding in 1905 as the Glendale Sanitarium, countless patients have entrusted its physicians, nurses and associates with their healthcare needs. Today, Adventist Health Glendale is the largest medical center serving the San Fernando Valley. As it continues to grow and evolve to better meet the needs of the communities it serves, its staff knows that exceptional healthcare is more than medicine. It’s about how Adventist Health Glendale chooses to care for its patients and each other – taking time to listen, to understand, to answer questions, to hold a hand, even to pray. Adventist Health Glendale has achieved major distinctions, including a five-star rating by the Centers for Medicare and Medicaid Services for quality care and outcomes; and 11 consecutive A grades for quality care from The Leapfrog Group. It has also been named as a Joint Commission “Top Performer” in the areas of stroke, cardiac care and pneumonia.


Founded in 1901, Children’s Hospital Los Angeles is a pediatric academic medical center built around its mission of creating hope and building healthier futures for children. Renowned for its world-class clinical care, leading-edge research and one of the most successful pediatric training programs in the country – all while being the pediatric safety net hospital for the entire region – CHLA performs more than 17,000 surgeries and sees more than 600,000 patient visits annually. Providing $316.2 million in community benefits, CHLA – at its core – reflects its physicians, nurses and clinical staff, who provide compassionate and lifesaving care for young patients hailing from all 50 states and more than 75 countries. In the U.S. News’ “Honor Roll of Best Children’s Hospitals,” CHLA ranks No. 1 in the Western United States and No. 5 nationally for the second straight Year. CHLA also had seven sub-specialties in the top 10 nationwide.


City of Hope is a world-renowned independent biomedical research and treatment center for cancer and diabetes that is setting the standards for precision oncology care, delivering impactful research discoveries, collaborating with industry and philanthropic partners, and influencing healthcare policy to transform the future of health. President and CEO Robert Stone’s vision for the future of City of Hope embraces the 100-plus-year-old institution’s legacy of serving humanity by advancing scientific and clinical research and partnering with like-minded organizations to speed cures to patients. That vision is to be at the center of eliminating cancer and diabetes, bringing the discoveries of tomorrow to people who need them today, collaborating through integrated networks of scientific innovation and deeply personalized care. City of Hope’s rapid evolution has included expanding access to its exceptional patient-centered care, as it has grown from a single site outside of Los Angeles to a clinical network spanning 30 locations.

UCLA HEALTH - Ronald Reagan UCLA Medical Center/UCLA Medical Center, Santa Monica

Ronald Reagan UCLA Medical Center and UCLA Medical Center, Santa Monica are the primary hospitals of UCLA Health, recognized for delivering the highest quality care and consistently ranked by U.S. News & World Report among the country’s best hospitals, leading UCLA Health for 30 consecutive years to be named to USNWR’s National Honor Roll. Reliably recognized for patient safety, each received an A in the Leapfrog Group’s latest quality-and-safety assessment, and they received the 2020 Healthgrades Outstanding Patient Experience Award. In addition, UCLA’s hospitals have been the busiest transplant centers in the nation, performing more than 18,800 procedures since 1988, when shared data collection began. The hospitals’ comprehensive preparation has also made them leaders in the COVID-19 response. Their clinical labs were among the first in the country to develop in-house testing for COVID-19, reducing the time to get results from several days to a few hours.



In response to the COVID-19 public health crisis, AltaMed Health Services, the nation’s largest federally qualified community health center, quickly reinvented the way it delivers care. As a community health center, AltaMed plays a vital role in providing access to medical services to all who seek care to reduce unnecessary ER visits and hospitalizations. In just 10 days, AltaMed launched the first of nine outdoor COVID-19 testing and medical evaluation sites in Los Angeles and Orange counties that were hit hardest with COVID-19 cases. Patients who were symptomatic were treated outdoors, leaving the health centers open for regular appointments. Testing was made available to anyone with symptoms, regardless of their ability to pay. From April 1 to June 5, 43,177 tests have been performed and each day, AltaMed had 417 staff working at its nine evaluation centers. The health centers quickly implemented telemedicine appointments for patients. From March 16 to June 7, 69,249 virtual visits were completed.


Throughout the pandemic, the Clinical Microbiology and Virology Laboratory in the Department of Pathology and Laboratory Medicine (PLM) at Children’s Hospital Los Angeles has played a vital role in keeping CHLA’s environment safe for patients, families and staff. In February, as the coronavirus was spreading through Italy and Iran, the laboratory director, Jennifer Dien Bard, Ph.D. D(ABMM), recognized the likelihood of a global pandemic. With the support of CHLA’s Department of Pathology and Laboratory Medicine, she and her team began the preparation to ensure that all the components required for continuous testing at CHLA, including test reagents and nasopharyngeal swabs, were procured and fully stocked before the pandemic. This testing capability enabled CHLA to test all CHLA staff exhibiting symptoms during daily health screenings – and testing all patients admitted for care and procedures. The laboratory expanded its operation to provide testing 24-7, testing with six-hour turnaround time to support clinical operations.


MiraDx is a Los Angeles-based molecular genetics company that identifies, validates, develops, and delivers novel germline biomarker tests for individualized cancer treatment. In March 2020, MiraDx paused its cancer patient testing and pivoted its resources to COVID-19 testing in response to the pandemic. Because MiraDx’s research is focused on studying DNA and RNA, the company was able to quickly repurpose its existing laboratory equipment and protocols to test for COVID-19, an RNA virus. The test developed is a highly-sensitive PCR test, which can detect if someone is contagious at the early stage of infection, regardless of whether they are displaying symptoms. MiraDx’s shift to create a coronavirus test amid the pandemic has had a positive impact on not just the surrounding LA community but the entire country. It has been able to expand testing to nationwide businesses as well as public and private universities, with programs that can be customized to the needs of each individual institution.


When USC Verdugo Hills Hospital (USC-VHH) in Glendale first realized the risks of COVID-19 in January, the leadership and the infection prevention team immediately developed plans to ration supplies, screen patients and keep patients and staff safe. Hospital leadership also held free seminars throughout the Glendale area to inform the public. As the pandemic took hold, USC-VHH took a bold step by publicly providing daily tallies of how many patients and staff tested positive or were treated for COVID 19. This transparent approach gained the praise and trust of the community. USC-VHH also created highly effective infection prevention protocols to limit the spread of the virus, resulting in a very low infection rate of 0.3% among staff when they were tested in May. One innovation keeping rates down: patients arriving to the Emergency Department with symptoms of COVID-19 are screened at telemedicine stations, which protects both staff and patients from possible exposure to the virus while preserving personal protective equipment.



Celebrating its 100th year of community health service, Eisner Health continues to be an organization that provides quality health care and is a tremendous asset to the Los Angeles community. Currently, Eisner Health operates 16 sites and has more than 200,000 patient visits and with 50,000 plus unduplicated patients. Eisner Health offers a wide variety of medical services including pediatrics, dental, women’s health, prenatal care/education, adult care, midwifery, and a Daddy Boot camp. It also provides school-based health and dental care to some LAUSD students on their school campuses. Eisner Health prides itself as a place providing quality care and as an organization where people want to work in furtherance of its mission. The staff is one of the greatest assets of Eisner Health. Because many staff members are long time employees, patients feel welcomed and comfortable, and the institution benefits from their collective institutional knowledge.


Heal One World was formed in 2009 and for 11 years has served the community in Los Angeles with free classes and individual instruction and care. The impact of Heal One World on the community is profound, with people from different backgrounds converging in a welcoming space for self-knowledge from the physical and mental practices of tai chi, yoga and meditation. The organization has worked with the Venice Family Clinic, Saban Clinic, Salvation Army, Bresee Foundation, LAMP, Healthcare for the Homeless, PATH, Pilgrim and Vista Towers Senior Housing, Front Porch Seniors US Vets and the Veterans Administration. This is in addition to the organization’s space in mid-city, where the classes have been held since 2010, serving over 10,000 community members. Since COVID-19, Heal One World has begun offering free online yoga, meditation, tai chi, bootcamp and energy classes. There have been hundreds of participants enjoying the live classes.


2020 marks Venice Family Clinic’s 50th Anniversary. Since its beginning as an all-volunteer operation in a borrowed office, the clinic has become a healthcare leader serving people in need across greater L.A., a pioneer in innovations that improve lives and an effective advocate for equal access to health care. It has grown to 12 sites in Venice, Santa Monica, Mar Vista, Inglewood, Hawthorne and Culver City, serving nearly 28,000 men, women and children in need, including 4,500 people experiencing homelessness. A vital local institution, the nonprofit community health center has demonstrated its importance to L.A.’s health throughout its history and especially now, with COVID-19 highlighting poorer health outcomes for people in poverty. The clinic led the way in expanding telehealth to protect patient and staff health and served as one of the only clinics offering in-person counseling during the pandemic.


Founded in 1974 as a women’s health clinic in Santa Monica, WFHC is a women-led, award winning FQHC that provides primary care and health education to 13,000 women, men and children. Its patients are among the 188,000 low-income or uninsured residents on LA’ s Westside with high rates of heart disease, diabetes, hypertension, and cancer. Nearly half of the center’s patients are uninsured. 93% of WFHC’s patients live at or below 200% of the FPL, and rely on WFHC’s affordable services to provide the quality health services they deserve. WFHC’s visionary President/CEO dreamed of a larger site that matched the dignity WFHC gives its patients. A million-dollar pledge kicked off years of planning and fundraising: WFHC found the perfect site to lease (former LA Weekly building) and built it out and moved during the pandemic. In this new space, WFHC can double the number of patients seen, and expand its services in 12,000 square feet of new clinic space.



Researchers from The Lundquist Institute (TLI), a biomedical research institute in Torrance, are at the forefront of calming fears, and providing expertise, on the COVID-19 pandemic for the community through multiple LA media outlets. TLI is conducting numerous federally sponsored COVID-19 clinical trials to test the most promising vaccines and therapies, as well as collecting hyperimmune serum from convalescent COVID-19 patients for use in preventing further spread of the virus. The research will gain a better understanding of the disease’s frequency and spread in multi-ethnic, minority and underserved populations. Despite shutdowns resulting from the pandemic, TLI found a way to continue its life-saving endeavors, including finding treatments for children with the fatal Sanfilippo syndrome, or “childhood Alzheimer’s.” TLI has achieved major milestones in the field of healthcare innovation over the last year, including: the first and only FDA-approved treatment for Thyroid Eye Disease, marking it the third FDA-approved product developed at TLI in five years.


Founded in 2013 by Dr. Joanne Weidhaas, MiraKind is the non-profit research arm of MiraDx, focused on applying Dr. Weidhaas’ discovery of a novel class of genetic mutations to develop cancer prevention strategies. MiraKind aims to instill change in the cancer research industry by breaking down the barriers between doctors, scientists, and patients to validate novel findings and to ask the questions that will lead to actionable strategies to reduce cancer risk and suffering. MiraKind provides women, especially women of menopause age with or without a cancer diagnosis, easy access to genetic information that can help them understand their potential risk for certain cancers, detail the cause of their personal or family histories of cancer, and determine whether they should consider hormone replacement therapy as a preventative strategy, if they are KRAS-variant positive. MiraKind also specifically conducts research on the KRAS-variant and other mutations like it.


The Pacific Neuroscience Institute is devoted to providing personalized, precision multidisciplinary patient care; advancing the neurosciences and promoting brain health through novel research and innovative clinical trials; training the next generation of clinician and research neuroscientists; and educating patients and the community at large on vital neuroscience issues. The Pacific Neuroscience Institute is home to a family of doctors, nurses and staff who are committed to not only providing patients with the best quality care but also advancing the field of neurosurgical and neurooncological medicine. From cutting edge surgeries to groundbreaking clinical trials, the organization goes above and beyond to treat patients and provide pioneering research.


The UCLA Jonsson Comprehensive Cancer Center is one of 51 comprehensive cancer centers in the nation, the highest designation possible from the National Cancer Institute, recognizing state-of-the-art research focused on developing new and better approaches to preventing, diagnosing, and treating cancer. The Cancer Center has become a leader in cancer research and clinical care, establishing itself in a rapidly changing field. Numerous successful targeted therapies and immunotherapies were developed based on basic science done in UCLA laboratories and later in clinical research with UCLA patients. The Cancer Center’s 500 scientists and physicians are changing the treatment paradigms for patients with cancer. Since 2014, the U.S. Food & Drug Administration has approved 13 therapies that were developed through research conducted in UCLA labs. Pioneering UCLA research led to the development of the breast cancer drug Herceptin.



Although rules vary by state and license type, mental health professionals typically must complete an average of 12-20 hours of continuing education (CE) annually. SimplePractice Learning is a CE platform offering premium-quality, engaging and relevant courses for mental health professionals. Professionals can grow their expertise with courses taught by leading experts, including Couples and Families, Diagnoses, Diversity, Documentation, Law and Ethics, Supervision, Technology, and more. The SimplePractice Learning curriculum is developed in collaboration with leading experts in their field of study. The company developed innovative, unique and relevant coursework mental health professionals aren’t able to find anywhere else. Courses are filmed with a cinematic look and feel to them, far surpassing the fluorescent lights and lousy audio of other offerings. Presenters are selected for their specialized knowledge and teaching skill, with an emphasis on diversity in backgrounds and viewpoints.


With $300 million in sponsored funding, 14 clinical departments and six basic science departments, the David Geffen School of Medicine at UCLA was ready to tackle the coronavirus when it arrived in California. The challenge? Life-saving treatments require patients to validate findings, and clinical trials normally take at least three months to launch. Researchers must run a gauntlet of time-intensive steps: writing a study protocol, negotiating a budget and contract, and obtaining regulatory approvals to ensure patient safety. To speed up the process, the Office for Clinical Research, overseen by UCLA’s medical school and Clinical and Translational Science Institute, created a rapid-response team for each frontline investigator. This enabled scientists to focus on research and patient care while the team completed administrative tasks. Moving forward, the accelerated trial roadmap will also benefit non-COVID patients as UCLA applies it to research in other diseases.



Right at Home is a leader in the in-home senior care industry. Its trained caregivers provide quality in-home care for seniors and disabled adults who need some assistance to maintain their independence. The organization is an in-home care company that operates through independently owned and operated home care franchisees. During the COVID 19 crisis, Right at Home led the industry in Los Angeles in supplying free masks (surgical and N95), gloves, face shields and isolation gowns to their staff and clients for both their protection and the greater protection of the community Right at Home serves. Since 2008, Right at Home has supplied the highest quality of senior care, having helped over 2000 individuals in that time and has been rated a Super Star of Caring by based on customer reviews. It has worked closely with the Parkinson’s Foundation, the MS Foundation, Alzheimer’s Los Angeles, the Assistance League, People’s Coordinated Services, USC Caregiving Resource Center, and many more.


WorXsiteHR’s cost containment strategy all starts with its HealthWorX program. HealthWorX is a new kind of health insurance company that uses an innovative approach and technology platform to empower employers to provide low-wage and part-time employees with ERISA and ACA-compliant healthcare at no net cost. The company focuses on providing access to care and the overall experience of users, ensuring that neither employers nor employees bear the burden of expensive healthcare plans. HealthWorX focuses on the wellbeing of all. HealthWorX offers unlimited, preventative and sick visits with no deductibles and small copays; telemedicine for employees and dependents, full wellness programs, and pharmacy benefits through GoodRx. By using this program, CEOs and franchise owners save approximately $35 per month per participant. Meaning that if an employer has 1,000 employees on the program, that employer can save $35,000 per month or $420,000 a year in FICA.

Return to HCPA Recap Homepage

For reprint and licensing requests for this article, CLICK HERE.